S. Westphalen

Phytoestrogens for hormone replacement therapy?

H. Jarry, D. Seidlová-Wuttke, W. Wuttke, 2002, The Journal of Steroid Biochemistry and Molecular Biology.

Biology of the gonadotropin-releasing hormone system in gynecological cancers.

G. Emons, C. Gründker, A. Günthert, 2002, European journal of endocrinology.

Phytoöstrogene – eine Alternative zur Standardhormonersatztherapie?

H. Jarry, W. Wuttke, S. Westphalen, 2002, Der Gynäkologe.

GnRH antagonists in the treatment of gynecological and breast cancers.

G. Emons, C. Gründker, J. Kavanagh, 2003, Endocrine-related cancer.

International Congress on Hormonal Steroids and Hormones and Cancer GnRH antagonists in the treatment of gynecological and breast cancers

C. Verschraegen, G. Emons, J. Kavanagh, 2003 .

High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.

A. Schally, G. Emons, O. Ortmann, 1993, The Journal of clinical endocrinology and metabolism.

Pseudo-Meigs Syndrome: Uterine Leiomyoma with Bladder Attachment Associated with Ascitesand Hydrothorax – a Rare Case of a Rare Syndrome

A. Fayyazi, G. Emons, T. Krauss, 2002, Oncology Research and Treatment.

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.

C. Verschraegen, A. Kudelka, Wei Hu, 2003, Gynecologic oncology.

Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.

A. Schally, G. Emons, F. Kaiser, 2000, International journal of oncology.